These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 3188535
1. [Heparin in deep venous thrombosis of the leg--effectiveness and safety]. Gatterer E, Stöllberger C, Slany J, Stöberl C, Jaksch J. Wien Klin Wochenschr; 1988 Sep 23; 100(18):601-5. PubMed ID: 3188535 [Abstract] [Full Text] [Related]
2. Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis--a randomized clinical trial. Pini M, Pattachini C, Quintavalla R, Poli T, Megha A, Tagliaferri A, Manotti C, Dettori AG. Thromb Haemost; 1990 Oct 22; 64(2):222-6. PubMed ID: 2270531 [Abstract] [Full Text] [Related]
3. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. Monreal M, Lafoz E, Olive A, del Rio L, Vedia C. Thromb Haemost; 1994 Jan 22; 71(1):7-11. PubMed ID: 8165649 [Abstract] [Full Text] [Related]
4. [Heparin treatment. Comparison between intravenous and subcutaneous administration]. Krähenbühl B, Simon CA, Bouvier CA, Schinas P, Hopf MA, Cochet B. Schweiz Med Wochenschr; 1979 Sep 22; 109(36):1322-5. PubMed ID: 504973 [Abstract] [Full Text] [Related]
5. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis. Simonneau G, Charbonnier B, Decousus H, Planchon B, Ninet J, Sie P, Silsiguen M, Combe S. Arch Intern Med; 1993 Jul 12; 153(13):1541-6. PubMed ID: 8391792 [Abstract] [Full Text] [Related]
12. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P, Behounek J, Skoták M, Nevsímal L. Acta Chir Orthop Traumatol Cech; 2004 May 09; 71(4):237-44. PubMed ID: 15456102 [Abstract] [Full Text] [Related]
15. Physician practices in the treatment of pulmonary embolism and deep venous thrombosis. Wheeler AP, Jaquiss RD, Newman JH. Arch Intern Med; 1988 Jun 09; 148(6):1321-5. PubMed ID: 3377615 [Abstract] [Full Text] [Related]
16. Comparison of the cost-effectiveness of administering heparin subcutaneously or intravenously for the treatment of deep vein thrombosis. Barber ND, Hoffmeyer UK. Ann R Coll Surg Engl; 1993 Nov 09; 75(6):430-3. PubMed ID: 8285546 [Abstract] [Full Text] [Related]
18. A comparison between low molecular weight heparin (KABI 2165) and standard heparin in the intravenous treatment of deep venous thrombosis. Bratt G, Törnebohm E, Granqvist S, Aberg W, Lockner D. Thromb Haemost; 1985 Dec 17; 54(4):813-7. PubMed ID: 3911482 [Abstract] [Full Text] [Related]
19. Heparin treatment of deep vein thrombosis. Effects and complications after continuous or intermittent heparin administration. Fagher B, Lundh B. Acta Med Scand; 1981 Dec 17; 210(5):357-61. PubMed ID: 7039244 [Abstract] [Full Text] [Related]